Influenza vaccination of children: Can it be accomplished?

Journal of Infectious Diseases

Volumn 194, Issue 8, 2006, Pages 1027-1029

  Edwards, Kathryn M ^a,b   Griffin, Marie R ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

CANADA; CHILD; CHILD HOSPITALIZATION; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; DISEASE TRANSMISSION; DRUG TOLERABILITY; EDITORIAL; EPIDEMIC; HEALTH CARE COST; HEALTH CARE PLANNING; HUMAN; IMMUNIZATION; INFECTION CONTROL; INFLUENZA; INFLUENZA VACCINATION; JAPAN; MONITORING; MORBIDITY; MORTALITY; NONHUMAN; PRIORITY JOURNAL; VIRUS IMMUNITY; VIRUS STRAIN;

CHILD; CHILD HEALTH SERVICES; HUMANS; IMMUNIZATION SCHEDULE; INFLUENZA A VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; UNITED STATES; VACCINATION;

EID: 33749584287     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/507315     Document Type: Editorial

References (17)

1. Glezen WP, Couch RB. Interpandemic influenza in the Houston area, 1974-76. N Engl J Med 1978; 298:587-92.
2. Neuzil KM, Mellen BG, Wright PF, Mitchel EF Jr, Griffin MR. The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. N Engl J Med 2000; 342:225-31.
3. Neuzil KM, Zhu Y, Griffin MR, et al. Burden of interpandemic influenza in children younger than 5 years: a 25-year prospective study. J Infect Dis 2002; 185:147-52.
4. O'Brien MA, Uyeki TM, Shay DK, et al. Incidence of outpatient visits and hospitalizations related to influenza in infants and young children. Pediatrics 2004; 113(Pt 1):585-93.
5. Halloran ME, Longini IM Jr. Public health: community studies for vaccinating schoolchildren against influenza. Science 2006; 311:615-6.
6. Reichert TA, Sugaya N, Fedson DS, Glezen WP, Simonsen L, Tashiro M. The Japanese experience with vaccinating schoolchildren against influenza. N Engl J Med 2001; 344:889-96.
7. Neuzil KM, Jackson LA, Nelson J, et al. Immunogenicity and reactogenicity of 1 versus 2 doses of trivalent inactivated influenza vaccine in vaccine-naive 5-8-year-old children. J Infect Dis 2006; 194:1032-9 (in this issue).
8. Centers for Disease Control and Prevention. Childhood influenza-vaccination coverage-United States, 2002-03 influenza season. MMWR Morb Mortal Wkly Rep 2004; 53:863-6.
9. Centers for Disease Control and Prevention. Childhood influenza vaccination coverage-United States, 2003-04 influenza season. MMWR Morb Mortal Wkly Rep 2006; 55:100-3.
10. Zimmerman L, Bartlett D, Gosney K, Enger K, Williams W. Influenza vaccination coverage among children aged 6-23 months, 2004-2005. Available at: http://cdc.confex.com/cdc/nic2006/techprogram/P10084.HTM. Accessed 1 September 2006.
11. Kwong JC, Sambell C, Johansen H, Stukel TA, Manuel DG. The effect of universal influenza immunization on vaccination rates in Ontario. Health Rep 2006; 17:31-40.
12. Kempe A, Daley MF, Barrow J, et al. Implementation of universal influenza immunization recommendations for healthy young children: results of a randomized, controlled trial with registry-based recall. Pediatrics 2005; 115:146-54.
13. Ma KK, Schaffner W, Colmenares C, Howser J, Jones J, Poehling KA. Influenza vaccinations of young children increased with media coverage in 2003. Pediatrics 2006; 117:e157-63.
14. Szilagyi PG, Iwane MK, Schaffer S, et al. Potential burden of universal influenza vaccination of young children on visits to primary care practices. Pediatrics 2003; 112:821-8.
15. Englund JA, Walter EB, Fairchok MP, Monto AS, Neuzil KMA. Comparison of 2 influenza vaccine schedules in 6- to 23-month-old children. Pediatrics 2005; 115:1039-47.
16. King JC Jr, Cummings GE, Stoddard J, et al. A pilot study of the effectiveness of a school-based influenza vaccination program. SchoolMist Study Group. Pediatrics 2005; 116:e868-73.
17. Piedra PA, Gaglani MJ, Riggs M, et al. Live attenuated influenza vaccine, trivalent, is safe in healthy children 18 months to 4 years, 5 to 9 years, and 10 to 18 years of age in a community-based, nonrandomized, open-label trial. Pediatrics 2005; 116:e397-407.